Question: is zelnorm back on the market?
Answer: Yes. The FDA approved the reintroduction of Zelnorm (tegaserod) for the treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in women under 65 years of age, in late March 2019. It is expected to become available in the months following the announcement.